n-(1-pyrenyl)iodoacetamide has been researched along with raloxifene hydrochloride in 1 studies
| Studies (n-(1-pyrenyl)iodoacetamide) | Trials (n-(1-pyrenyl)iodoacetamide) | Recent Studies (post-2010) (n-(1-pyrenyl)iodoacetamide) | Studies (raloxifene hydrochloride) | Trials (raloxifene hydrochloride) | Recent Studies (post-2010) (raloxifene hydrochloride) |
|---|---|---|---|---|---|
| 33 | 0 | 3 | 2,818 | 481 | 810 |
| Protein | Taxonomy | n-(1-pyrenyl)iodoacetamide (IC50) | raloxifene hydrochloride (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.0053 | |
| Gastric inhibitory polypeptide receptor | Homo sapiens (human) | 0.0004 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.1297 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baer, BR; Rock, DA; Wienkers, LC | 1 |
1 other study(ies) available for n-(1-pyrenyl)iodoacetamide and raloxifene hydrochloride
| Article | Year |
|---|---|
Time-dependent inactivation of P450 3A4 by raloxifene: identification of Cys239 as the site of apoprotein alkylation.
Topics: Alkylating Agents; Alkylation; Apoproteins; Binding Sites; Cysteine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Endopeptidase K; Enzyme Inhibitors; Estrogen Antagonists; Glutathione; Iodoacetamide; Kinetics; Midazolam; Molecular Structure; Quinolines; Raloxifene Hydrochloride; Recombinant Proteins; Sequence Analysis, Protein; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Time Factors | 2007 |